Malaria-on-a-Chip Model
Malaria
Pre-clinicalActive
Key Facts
About Hesperos
Hesperos is a privately held, US-based biotech firm founded in 2015, specializing in advanced organ-on-a-chip systems. Its core technology involves interconnected, reconfigurable platforms that simulate the functional aspects of human organs, aiming to reduce animal testing and improve the predictability of drug development. The company operates a service-based business model, offering custom disease modeling and drug testing assays to research institutes and pharmaceutical partners. Hesperos is positioned as a leader in this niche field, leveraging strong academic foundations and intellectual property.
View full company profileOther Malaria Drugs
| Drug | Company | Phase |
|---|---|---|
| Vaxine Malaria Vaccine | Vaxine | Preclinical |
| Malaria Vaccine | VLP Biotech | Pre-clinical |
| Malaria Antibodies | new/era/mabs | Research/Pre-clinical |
| Dendritic Cell Vaccine | MegaNano BioTech | Pre-clinical |
| Malaria | Keltic Pharma Therapeutics | Pre-clinical |
| Antibody Programs (Malaria) | Ibex Biosciences | Pre-clinical |
| Malaria RDTs | Access Bio | Commercial |
| Malaria Nanobody | VicuTec Biologicals | Pre-clinical |